Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

BACKGROUND: Current treatments for chronic hepatitis B are suboptimal. In the search for improved therapies, we compared the efficacy and safety of pegylated interferon alfa plus lamivudine, pegylated interferon alfa without lamivudine, and lamivudine alone for the treatment of hepatitis B e antigen...

Full description

Saved in:
Bibliographic Details
Main Authors: George K.K. Lau, Teerha Piratvisuth, Xian Luo Kang, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Cheng Chow Wan, Woon Paik Seung, Yu Chang Wen, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck
Format: Journal
Published: 2018
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=21244447705&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/62382
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=21244447705&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/62382

Similar Items